Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06726590 · ClinicalTrials.gov registry record
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
A clinical trial of Cancer and Diabetes, sponsored by Texas A&M University.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT06726590 is a study of Cancer and Diabetes that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 3,000 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06726590, a study of Cancer and Diabetes, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This program collects genetic and health information to help doctors choose the right medications for patients.
Conditions Studied
Study Locations (1)
Texas
- Texas A&M Family Care - Bryan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2025-11 |
| Est. Completion | 2029-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06726590
The ClinicalTrials.gov registry entry for NCT06726590 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06726590 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06726590 about?
NCT06726590 is a clinical study titled "Interprofessional Pharmacogenomics (IPGx) Registry and Repository". This program collects genetic and health information to help doctors choose the right medications for patients.
What is the current status of trial NCT06726590?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2025-11. Estimated completion is 2029-11.
What conditions does trial NCT06726590 study?
This clinical trial studies the following conditions: Cancer, Diabetes, COPD, Heart Disease, Blood Pressure Disorders.
Who is sponsoring clinical trial NCT06726590?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06726590 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.